1.Pain Relief
People who used pot to ease their pain didn’t have an increased risk of serious side effects, compared to people with pain who didn’t use marijuana, a Canadian research team found.
But, medical marijuana users were more much likely to have low serious side effects, the study authors said. These side effects includes headache,nausea, sleepiness and dizziness, the research revealed.
One of the most common applications for medical marijuana is pain, whether it’s inflammation, headaches, neuropathic pain, muscle soreness, spinal injury, fibromyalia, or cramps. Both of the most commonly compounds in marijuana ease pain Believe it or not, research is showing that medical marijuana may interact with your pain signaling cells. Both THC and CBD are strong anti-inflammatories. They also interact with other pain systems in your body.
2.AUTOIMMUNE DISEASES
The symptoms of these disorders leaves the patients at any level of fatigue, pain in the muscles or other areas of the body, fevers, and uncontrollable ticks or muscle movements or lack thereof, depending on the disease. Only one drug at the moment has been created and found to effectively slow the advancement of Lou Gehrig’s disease, and a host of medications are prescribed for all other autoimmune disorders that can bring few relief or retard the downward spiral of many others.
Marijuana is now regularly and successfully used to alleviate the nausea and vomiting many cancer patients experience as side effects to chemotherapy, combat the wasting syndrome that causes some AIDS patients to lose significant amounts of weight and muscle mass and ease chronic pain that is unresponsive to opioids, among other applications.
Published in the Journal of Biological Chemistry, the findings say marijuana’s potential key role in fighting these diseases lies in its capacity to suppress certain immune functions, notably inflammation. Autoimmune diseases arise from an overactive immune responses of the body against substances and tissues normal presently in the body. MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs that play a vital role in regulating gene expression. And the authors claim that the ability to alter miRNA expression may be the key to successful treatment for many autoimmune diseases, including multiple sclerosis, arthritis and type 1 diabetes.
3.Glaucoma
Medical marijuana is promoted as a treatment for many diseases, including glaucoma.Glaucoma is an eye condition in which the optic nerve becomes damaged over time, reducing side vision. It sometimes leads to blindness.
Treatments that lower the pressure in the eye both lower the risk of developing the optic nerve damage that defines glaucoma, and the risk of pre-existing damage getting worse.
Marijuana can help your glaucoma and it could absolutely get you in trouble because it’s illegal. Cannabis really does counteract glaucoma. It’s a medical fact. Unfortunately, the effects only last about three hours, and it seems that the most effective cannabinoids are also the most psychoactively potent. It is estimated that more than 3 million Americans suffer from glaucoma, a disease of the major nerve of vision called the optic nerve.
4.STIMULATING APPETITE
Cannabis’ ability to stimulate appetite is well known on a casual level, but clinical trials on medical marijuana as an appetite stimulant provide scientific evidence as well. The primary active compound in cannabis, tetrahydrocannabinol or THC, is believed to be the single most active chemical in cannabis abilities to stimulating appetite.
In this study, the authors used a synthetic form of delta-9-THC, which is marketed as dronabinol .Dronabinol was first licensed and approved in 1986 for the treatment of nausea and vomiting associated with chemotherapy; the indication was expanded in 1992 for the treatment of anorexia associated with weight loss in patients with AIDS. Surprisingly, the researchers discovered that the appetite stimulating effects of marijuana are driven by the same neurons in the brain which usually suppress the appetite, the exact opposite of what most researchers thought prior to Horvath’s study.
credit:marijuana.com
